The cause of the complement activation on cardiomyocytes during ischemia has not been clarified, but it was suggested that ischemia determines the plasma membrane damage resulting in the cellular loss of the capacity to inactivate the C3b components responsible for C5 activation and C5b-9 self-attach of the cell [62]. The gene discussed is C5; the disease is ischemia.